WallStSmart

Johnson Controls International PLC (JCI)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Johnson Controls International PLC generates 104% more annual revenue ($23.97B vs $11.77B). JCI leads profitability with a 14.2% profit margin vs 12.0%. JCI appears more attractively valued with a PEG of 2.63. WELL earns a higher WallStSmart Score of 57/100 (C).

JCI

Buy

57

out of 100

Grade: C

Growth: 6.7Profit: 6.0Value: 3.7Quality: 4.3
Piotroski: 5/9Altman Z: 1.11

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for JCI.

WELLSignificantly Overvalued (-57.2%)

Margin of Safety

-57.2%

Fair Value

$132.26

Current Price

$216.47

$84.21 premium

UndervaluedFair: $132.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JCI2 strengths · Avg: 8.5/10
Market CapQuality
$88.38B9/10

Large-cap with strong market position

EPS GrowthGrowth
34.2%8/10

Earnings expanding 34.2% YoY

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Market CapQuality
$153.12B9/10

Large-cap with strong market position

Areas to Watch

JCI3 concerns · Avg: 2.0/10
PEG RatioValuation
2.632/10

Expensive relative to growth rate

P/E RatioValuation
48.8x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.112/10

Distress zone — elevated risk

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

PEG RatioValuation
3.662/10

Expensive relative to growth rate

P/E RatioValuation
105.3x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : JCI

The strongest argument for JCI centers on Market Cap, EPS Growth.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : JCI

The primary concerns for JCI are PEG Ratio, P/E Ratio, Altman Z-Score. A P/E of 48.8x leaves little room for execution misses.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.3x leaves little room for execution misses.

Key Dynamics to Monitor

JCI profiles as a value stock while WELL is a growth play — different risk/reward profiles.

JCI carries more volatility with a beta of 1.39 — expect wider price swings.

WELL is growing revenue faster at 38.3% — sustainability is the question.

JCI generates stronger free cash flow (464M), providing more financial flexibility.

Bottom Line

JCI scores higher overall (57/100 vs 57/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Johnson Controls International PLC

INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT · USA

Johnson Controls International plc is an Irish-domiciled multinational conglomerate headquartered in Cork, Ireland, that produces fire, HVAC, and security equipment for buildings.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?